Product Overview
Palbociclib API is a selective cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor.
Used in targeted cancer therapy.
Comes with a higher amount of purity, making it suitable for pharmaceutical preparations.
Therapeutic Applications
It is helpful towards hormone receptor-positive (HR+), HER2-negative advanced breast cancer.
Palbociclib is seen to be helpful against breast cancer treatment.
Often useful in combination with aromatase inhibitors.
It may also be investigated for other cancers involving the CDK4/6 pathway.
Specification Parameters
The CAS number is 571190-30-2
The molecular formula is C24H29N7O2, and the molecular weight is 447.54 g/mol.
Palbociclib is an off-white to yellow crystalline powder.
Purity available is ≥ 99% (HPLC)
Slightly soluble in water.
Packaging & Storage
Supplied in sealed aluminum foil bags or HDPE containers.
Large bulk packaging is available for industrial use.
The suitable temperature is between 2 and 8 °C, and in a closed container.
Why Choose Us
We provide high-purity products with strict quality control. Palbociclib is one of them.
Our consistent supply and timely delivery worldwide are available to us.
Flexible options for packaging and commercial requirements are achieved by us.
Complete product documentation is supported.
